IMPLITAPIDE: 50 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
50
Total FAERS Reports
50 (100.0%)
Deaths Reported
11
Hospitalizations
50
As Primary/Secondary Suspect
First Report: 20180802 · Latest Report: 20180802
What Are the Most Common IMPLITAPIDE Side Effects?
#1 Most Reported
Disease progression
50 reports (100.0%)
#2 Most Reported
Type iia hyperlipidaemia
49 reports (98.0%)
#3 Most Reported
Pleural effusion
11 reports (22.0%)
All IMPLITAPIDE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 50 | 100.0% | 50 | 11 |
| Type iia hyperlipidaemia | 49 | 98.0% | 49 | 10 |
| Abdominal pain | 11 | 22.0% | 11 | 11 |
| Cholecystitis acute | 11 | 22.0% | 11 | 11 |
| Hypotension | 11 | 22.0% | 11 | 11 |
| Liver injury | 11 | 22.0% | 11 | 11 |
| Nausea | 11 | 22.0% | 11 | 11 |
| Pleural effusion | 11 | 22.0% | 11 | 11 |
Who Reports IMPLITAPIDE Side Effects? Age & Gender Data
Gender: 0.0% female, 100.0% male. Average age: 59.0 years. Most reports from: CA. View detailed demographics →
Is IMPLITAPIDE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2018 | 1 | 1 | 1 |
What Is IMPLITAPIDE Used For?
| Indication | Reports |
|---|---|
| Type iia hyperlipidaemia | 49 |
Official FDA Label for IMPLITAPIDE
Official prescribing information from the FDA-approved drug label.